| 标题 |
[求助补充材料]
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Diabetes & Endocrinology 作者:Bo Åhrén; Luís Masmiquel; Harish Kumar; Mehmet Sargın; Julie Derving Karsbøl; et al 出版日期:2017-04-03 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)